Brain Metastases In ErbB2-Positive Breast Cancer

Clinical trial NCT00437073 · TERMINATED

Trial details

NCT number: NCT00437073
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2007-05-01
Primary completion: 2009-01-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.